De novo immune checkpoint inhibitor-associated inflammatory arthritis occurs in 2.87% of patients in real-world cohorts
Cancer treatments can cause joint and muscle inflammation in some patients
This meta-analysis of real-world cohorts identifies a 2.87% occurrence of de novo immune checkpoint inhibitor-associated inflammatory arthri…
New data shows that some patients on immune checkpoint inhibitors may develop specific types of inflammatory arthritis and muscle pain.
Secukinumab plus prednisone taper improves remission rates in recently relapsed polymyalgia rheumatica
Trial shows secukinumab helps patients with polymyalgia rheumatica remission
This Phase 3 randomized controlled trial of 381 patients with recently relapsed polymyalgia rheumatica found that secukinumab plus a 24-week…
A new trial shows that adding secukinumab to a steroid taper helps more people with polymyalgia rheumatica reach long-term remission.
Precision glucocorticoid dosing remains investigational; genetic markers not yet clinically actionable
New research explores personalized dosing for steroid medications
This guideline review outlines a precision medicine framework for glucocorticoid therapy in immune-mediated diseases, incorporating pharmaco…
Doctors are looking at how genetic testing and biomarkers can help tailor steroid doses for people with inflammatory diseases.
Narrative review discusses screening and prevention in rheumatic and musculoskeletal disease populations
Joint Pain May Signal Hidden Risk in Your Legs
This narrative review examines patients with rheumatic and musculoskeletal diseases (RMDs), including rheumatoid arthritis and systemic lupu…
Inflammation from autoimmune conditions can silently damage blood vessels in your legs.